WHO Unveils Global Blueprint to Combat Fungal Disease Crisis Cotonou, Benin — The World Health Organization (WHO) has unveiled a comprehensive global blueprint to address the escalating threat of fungal diseases, which currently affect over 300 million people annually.
The initiative, launched on 1 July 2026, aims to strengthen national and regional responses to fungal diseases and antifungal resistance, building on the WHO fungal priority pathogens list.
The blueprint is a critical step forward in addressing the gaps in fungal disease management and antifungal resistance.
Fungal diseases are largely absent from national health plans and global burden — of-disease estimates, despite their significant impact on public health and the environment.
The widespread use of antifungals in various sectors has contributed to the rise in antifungal resistance, exacerbating the problem.
According to the WHO, fungal diseases range from common conditions such as ringworm and nail infections to severe invasive diseases that can be deadly, especially for people with weakened immune systems.
The growing threat of antifungal resistance is further eroding an already limited number of antifungal medicines.
The blueprint identifies critical gaps across awareness, workforce capacity, diagnostics, access to treatment, surveillance, stewardship, and research, particularly in low — and middle-income countries. It presents integrated, equity-oriented, and One Health approaches to help address these gaps.
Officials commented on the matter.
Soumya Swaminathan, WHO’s Chief Scientist. “By strengthening our responses, we can save lives, reduce suffering, and minimize economic losses. “.
The WHO has also identified that fungal diseases are often missing from national health treatment policies, global burden — of-disease estimates, and most strategies on antimicrobial resistance (AMR), universal health coverage, and One Health.
The blueprint builds on the WHO fungal priority pathogens list and existing WHO work on neglected tropical diseases, HIV, and antimicrobial resistance. It provides countries with practical guidance to strengthen national and regional responses to fungal disease and antifungal resistance.
The initiative is expected to have a significant impact on the global health landscape, particularly in regions where fungal diseases are most prevalent. It also aims to improve the surveillance and reporting of fungal diseases, ensuring that they receive the attention they deserve.
As the blueprint is implemented, it will be crucial to monitor its effectiveness and make necessary adjustments to address any emerging challenges.
The WHO has called on all stakeholders, including governments, health organizations, and the private sector, to work together to combat this growing threat.
The launch of the blueprint marks a significant milestone in the global fight against fungal diseases. With the right strategies and resources, it is possible to make significant progress in reducing the burden of these diseases on individuals, communities, and economies worldwide.
*Additional reporting by ImNews | Sources consulted: 5*
—
This original article was produced by the ImNews editorial team
Source: Google News v2
